While many tech VCs are optimistic about Trump's second term, some healthcare investors feel stuck.
AdvertisementThe lower corporate taxes and deregulation a second Trump term could promise are already amplifying public market optimism.
She could be removed as the FTC's head early in Trump's second term — and with relaxed M&A regulations, "anything is possible," said What If Ventures founder Stephen Hays.
SOPA Images/Contributor/Getty ImagesMedicaid could also be targeted in Trump's second term.
A boon for healthcare AI and Medicare AdvantageTrump's victory could have a positive impact on several big areas of healthcare investment.
Persons:
—, Donald Trump's, Trump, He's, he'll, Robert F, Kennedy Jr, Trump's, Michael Greeley, Rebecca Noble, Tesla, JP Morgan Chase, Maven, Omada, Sean Duffy, Lina Khan, Stephen Hays, James Leynse, VCs, Carli Sapir, Jordan Nof, Greeley, Shiv Rao, Kennedy Jr's, Chrissy Farr, Phelps, Phillips, Farr
Organizations:
Trump, Service, Food and Drug Administration, Centers for Disease Control, Biden, Flare Capital Partners, Getty, Healthcare, Health, Cigna, Humana . Bloomberg, Federal Trade Commission, Investors, Business, Amboy Street Ventures, Tusk Venture, Senate, Affordable, Coalition for Health, Mayo Clinic, Johns Hopkins, Microsoft, Alignment Healthcare, Scrub
Locations:
Trump's Florida, Tuesday's, Trump's, Boston, America